Treatments for Multiple Myeloma 
CNN
If you've been recently diagnosed with multiple myeloma or have been living with the cancer for a while, you know that there's no one-size-fits-all treatment option. But that's actually good news. There are numerous therapies and medications that can ...

 

Hundreds take steps to raise money to cure a rare cancer, multiple myeloma 
NewsNet5.com
More than one hundred people were part of the Multiple Myeloma Research Foundation team. Multiple Myeloma is an incurable blood cancer with one of the worst survival rates of any type of cancer. The walkers and runners raised $25000 for the MMRF.

 

No Bisphosphonate Superior to Another in Multiple Myeloma 
Medscape
May 17, 2012 ? None of the bisphosphonates used as supportive therapy in multiple myeloma is superior to any of the others, according to a meta-analysis published online May 16 in the Cochrane Database of Systematic Reviews. The last Cochrane review ...
Bisphosphonates Cut Skeletal Morbidity in Multiple Myeloma Doctors Lounge
Bone Drugs Aid Myeloma Therapy MedPage Today
No Bone Drug Better Than Another dailyRx
Medical News Today 
all 8 news articles » 

Lenalidomide Maintenance for Multiple Myeloma Improves Survival 
Cancer Network
By Anna Azvolinsky, PhD | May 17, 2012 Three studies published this week show that lenalidomide improves progression-free and overall survival as a maintenance therapy in multiple myeloma, despite its link to other primary cancers.

 

Myeloma Research To Be Presented At The American Society of Clinical ... 
The Myeloma Beacon
The meeting will include many presentations and seminars focused specifically on multiple myeloma. The ASCO website currently lists nearly 50 myeloma-based presentations (included under ?lymphoma and plasma cell disorders?). The ASCO meeting is one of ...
New Data from Bristol-Myers Squibb Oncology Portfolio to be Presented at 2012 ... MarketWatch (press release)
Onyx Pharmaceuticals Announces Data Presentations at 48th American Society of ... PR Newswire (press release)

all 102 news articles » 

Drug Delays Relapse in Multiple Myeloma 
MedPage Today
Three trials of lenalidomide maintenance in multiple myeloma were all stopped early when progression-free survival was prolonged in those receiving lenalidomide compared with placebo. Note that one study focused on newly diagnosed multiple myeloma in ...
Lenalidomide Maintenance Beneficial in Multiple Myeloma Medscape
New Drug Shows Promise for Myeloma Patients U.S. News & World Report
Myeloma Canada Highlights Three Clinically Significant Studies Advancing ... MarketWatch (press release)
News-Medical.net  -PR Web (press release) 
all 33 news articles » 

Poli-sci professor's life honored by friends, family 
MSU State News
At the age of 73, Finifter died on October 29, 2011 after a two-year battle with multiple myeloma. On January 12, Abramson published an In Memoriam piece in the journal ?PS: Political Science & Politics? for his dear friend and colleague.

 

Lenalidomide prolongs disease control for multiple myeloma patients after stem ... 
EurekAlert (press release)
Multiple myeloma patients are better equipped to halt progression of this blood cancer if treated with lenalidomide, or Revlimid®, following a stem cell transplant, according to a study co-authored by a physician with the Oregon Health & Science ...

and more » 

Senesco to Present SNS01-T, an eIF5A-based Nanoparticle in a Phase 1b/2a Trial ... 
MarketWatch (press release)
The oral presentation, entitled "SNS01-T, an eIF5A-Based Gene Therapy Nanoparticle Designed for the Treatment of Multiple Myeloma, has Anti-Tumoral Activity in Lymphoma", will describe the effectiveness of SNS01-T in B-cell cancers, which is designed ...
Senesco Technologies Reports Fiscal 2012 Third Quarter Results PharmaLive.com (press release)

all 15 news articles » 

Lenalidomide prolongs disease control for multiple myeloma patients after stem ... 
Medical Xpress
Multiple myeloma patients are better equipped to halt progression of this blood cancer if treated with lenalidomide, or Revlimid, following a stem cell transplant, according to a study co-authored by a physician with the Oregon Health & Science ...
Revlimid (Lenalidomide) For Myeloma - Phase III Study Findings Medical News Today

all 4 news articles »